CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be accessible online the day of the symposium and for 3 weeks following. You must complete the process by July 1, 2024 in order to receive your certificate. Certificates will be available online until December 1, 2024 and are printable directly from the website.
The Symposium will be reviewed by an accrediting organization in the coming months. More information will post soon
This educational symposium will review the current epidemiology of cardiovascular disease in women, and examine women–specific cardiovascular issues related to diagnosis and treatment. Cardiovascular risk factors and diseases more common in women will be examined, including stress and ischemia without obstructive CAD. In addition, the effect of pregnancy-related hypertension and diabetes on future cardiovascular events will be discussed. The current guidelines for the management of congestive heart failure and atrial fibrillation will be reviewed with emphasis on sex-specific differences and considerations. State of the art therapies for aortic and mitral valve disease will be included, with an emphasis on sex-specific outcomes. This year will include a lecture dedicated to peripheral vascular disease, covering sex-specific epidemiology and management, as well as the prevention and management of chemotherapy-induced cardiotoxicity. Finally, cased-based presentations will highlight some of the ongoing dilemmas in cardiovascular management, and the use of novel pharmaceutical agents and invasive techniques. The objective of this symposium is to educate healthcare providers on sex-specific approaches in prevention, diagnosis and treatment of women with a broad range of cardiovascular diseases.
The overall objectives are to:
Heart disease is the leading cause of death in women in the U.S. and accounts for more deaths each year than all of the other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of a heart attack. Compared to men, women are less likely to receive standard of care of treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the impact of cardiovascular disease on women and empower them to be advocates for women's cardiovascular health.
This program has been designed to provide primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers with the necessary information to increase knowledge and awareness of cardiovascular disease in women with the goal of improving patient care.
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity.
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.
Complete Conference Management 3320 Third Avenue, Suite C San Diego, CA 92103 Phone 619-299-6673 Fax 619-299-6675 info@ccmmeetings.com > www.ccmmeetings.com